FR2310764A1 - Formes medicamenteuses solides, administrees par voie orale, de derives de xanthine solubles dans l'eau - Google Patents

Formes medicamenteuses solides, administrees par voie orale, de derives de xanthine solubles dans l'eau

Info

Publication number
FR2310764A1
FR2310764A1 FR7613720A FR7613720A FR2310764A1 FR 2310764 A1 FR2310764 A1 FR 2310764A1 FR 7613720 A FR7613720 A FR 7613720A FR 7613720 A FR7613720 A FR 7613720A FR 2310764 A1 FR2310764 A1 FR 2310764A1
Authority
FR
France
Prior art keywords
oral
water
solid drug
xanthine derivatives
drug forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7613720A
Other languages
English (en)
Other versions
FR2310764B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of FR2310764A1 publication Critical patent/FR2310764A1/fr
Application granted granted Critical
Publication of FR2310764B1 publication Critical patent/FR2310764B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR7613720A 1975-05-10 1976-05-07 Formes medicamenteuses solides, administrees par voie orale, de derives de xanthine solubles dans l'eau Granted FR2310764A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2520978A DE2520978C3 (de) 1975-05-10 1975-05-10 Dosierungseinheit einer festen, oral zu verabreichenden Arzneiform von wasserlöslichen Xanthin-Derivaten

Publications (2)

Publication Number Publication Date
FR2310764A1 true FR2310764A1 (fr) 1976-12-10
FR2310764B1 FR2310764B1 (fr) 1980-07-11

Family

ID=5946306

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7613720A Granted FR2310764A1 (fr) 1975-05-10 1976-05-07 Formes medicamenteuses solides, administrees par voie orale, de derives de xanthine solubles dans l'eau

Country Status (12)

Country Link
US (1) US4189469A (fr)
AU (1) AU502644B2 (fr)
BE (1) BE841617A (fr)
CY (1) CY1153A (fr)
DE (1) DE2520978C3 (fr)
DK (1) DK153918C (fr)
FR (1) FR2310764A1 (fr)
GB (1) GB1547232A (fr)
HK (1) HK42382A (fr)
KE (1) KE3219A (fr)
MY (1) MY8600617A (fr)
ZA (1) ZA762748B (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986006627A1 (fr) * 1985-05-15 1986-11-20 Riker Laboratories, Inc. Procedes et compositons de theophylline a liberation entretenue
EP0273005A1 (fr) * 1986-11-27 1988-06-29 Zyma SA Comprimé dispersible dans l'eau
EP0519820A1 (fr) * 1991-06-18 1992-12-23 Adir Et Compagnie Comprimé matriciel permettant la libération prolongée d'indapamide après administration par voie orale

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4491539A (en) * 1981-06-04 1985-01-01 The Procter & Gamble Company Liquid cleansing product with skin feel additives
DE3127237A1 (de) * 1981-07-10 1983-01-20 Hoechst Ag, 6000 Frankfurt Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
DE3508097A1 (de) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
US5200193A (en) * 1987-04-22 1993-04-06 Mcneilab, Inc. Pharmaceutical sustained release matrix and process
US4820522A (en) 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
US5085865A (en) * 1989-04-12 1992-02-04 Warner-Lambert Company Sustained release pharmaceutical preparations containing an analgesic and a decongestant
US5112827A (en) * 1990-05-18 1992-05-12 Board Of Regents, The University Of Texas System Drug to reverse fatty liver and atheromatous lesions
US5498802A (en) * 1995-02-28 1996-03-12 Hoechst Celanese Corporation Process for preparing omega-halo-ketones
US20040209900A1 (en) * 2003-04-15 2004-10-21 Hauptman Stephen P. Treatment of lipodystrophy (lipid redistribution syndrome)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065143A (en) * 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
US3864469A (en) * 1967-12-16 1975-02-04 Hoechst Ag Xanthines in pharmaceutical preparations and for stabilization of vitamins
DE1617418C3 (de) * 1967-12-16 1980-01-24 Hoechst Ag, 6000 Frankfurt Herstellung von festen Arzneimittelformen mit verzögerter Wirkstoffabgabe
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3590117A (en) * 1969-03-24 1971-06-29 Richardson Merrell Inc Long-lasting troche containing guar gum
US3639169A (en) * 1969-04-29 1972-02-01 Sucrest Corp Direct compression vehicles and method therefor

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986006627A1 (fr) * 1985-05-15 1986-11-20 Riker Laboratories, Inc. Procedes et compositons de theophylline a liberation entretenue
EP0273005A1 (fr) * 1986-11-27 1988-06-29 Zyma SA Comprimé dispersible dans l'eau
EP0519820A1 (fr) * 1991-06-18 1992-12-23 Adir Et Compagnie Comprimé matriciel permettant la libération prolongée d'indapamide après administration par voie orale
FR2677886A1 (fr) * 1991-06-18 1992-12-24 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.

Also Published As

Publication number Publication date
ZA762748B (en) 1977-04-27
DK153918B (da) 1988-09-26
AU502644B2 (en) 1979-08-02
DK205376A (da) 1976-11-11
HK42382A (en) 1982-10-08
MY8600617A (en) 1986-12-31
FR2310764B1 (fr) 1980-07-11
GB1547232A (en) 1979-06-06
DE2520978B2 (de) 1980-06-12
DE2520978C3 (de) 1981-02-19
BE841617A (fr) 1976-11-08
US4189469A (en) 1980-02-19
DK153918C (da) 1989-02-06
CY1153A (en) 1982-09-10
AU1376576A (en) 1977-11-17
KE3219A (en) 1982-08-13
DE2520978A1 (de) 1976-11-18

Similar Documents

Publication Publication Date Title
NL7808125A (nl) Farmaceutische preparaten van aluminiumzouten van ibuprofeen.
NL7607159A (nl) Werkwijzen voor de bereiding en toepassing van fenylazijnzuurderivaten.
NL190812C (nl) Werkwijze voor de bereiding van 1,4-dihydropyridinederivaten met vaatverwijdende en bloeddrukverlagende werking, alsmede farmaceutische preparaten die deze derivaten omvatten.
NL190721C (nl) Werkwijze voor het bereiden van 3-hydroxy-cephem derivaten.
NL7605749A (nl) Werkwijze voor de bereiding van 2,6-dimethyl-6- -gesubstitueerde heptaanderivaten.
FR2310764A1 (fr) Formes medicamenteuses solides, administrees par voie orale, de derives de xanthine solubles dans l'eau
NO141411C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive erytromycin-derivater
NL7606120A (nl) Werkwijze voor de bereiding van farmacologisch werkzame heteroarylderivaten.
BE847044A (fr) Derives de l'acide clavulanique,
MX3743E (es) Procedimiento para la preparacion de derivados 3,4-dihidro-2 (lh)-quinazolinona
NL186162B (nl) Werkwijze voor de bereiding van organotitanaten en voor de bereiding van mengsels waarin deze organotitanaten worden gebruikt.
NL7807453A (nl) Halogeenmethylderivaten van alpha-aminozuren.
NL7812600A (nl) Werkwijze ter bereiding van guanidinederivaten.
BE838094A (fr) Preparation de colorants azoiques solubles dans l'eau
NL7606178A (nl) Werkwijze voor de bereiding van farmacologisch actieve heteroarylderivaten.
NL7608297A (nl) Werkwijze voor de bereiding en toepassing van derivaten van gesubstitueerde n-alkylimidazolen.
NL7610059A (nl) Werkwijze voor de bereiding van 4-oxo-4h-benzo- pyranderivaten.
NL7707515A (nl) Werkwijze voor de bereiding van cyanuurzuur- derivaten.
NL7613307A (nl) Werkwijze voor het bereiden van 2(1h)-chinazo- linonderivaten.
NL7605172A (nl) Werkwijze voor de bereiding van 2-(2,2-dihalo- geenvinyl)-3,3-dimethylcyclopropaan-1-gesub- stitueerde derivaten.
NL7610057A (nl) Werkwijze voor de bereiding van farmaceutische preparaten.
NL7710336A (nl) Werkwijze voor de bereiding van anthrachinon- derivaten.
NL7604330A (nl) Werkwijze voor de bereiding van 8-azaprostaan- zuurderivaten.
NO159273C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzotriazol-derivater.
NL7613714A (nl) Trifluormethyldhioderivaten van cyproheptadine.